Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 19395 - 4763, Tehran, Iran.
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
BMC Nephrol. 2021 Mar 10;22(1):84. doi: 10.1186/s12882-021-02286-1.
As chronic kidney disease (CKD) is amongst the current global health challenges, this study is aiming to evaluate the long-term intake of total polyphenol and its subclasses in association with CKD incidence.
For the purpose of this study, a sample of 3021 Iranian adults (47 % men, aged 20-79 years) with no CKD diagnosis at baseline, were selected from the Tehran Lipid and Glucose Study population. The total intake of polyphenol and its major subclasses were assessed by a validated food frequency questionnaire and categorized as flavonoids, phenolic acids, stilbenes, and lignans. Although the morphological abnormalities of the kidneys or 3-month persistent urinalysis can distinctively define CKD, the glomerular filtration rate (eGFR) reduction is accepted as a more precise index of renal function. Therefore, eGFR < 60 mL/min/1.73m was the exclusive index of CKD diagnosis in the current study. The eGFR was calculated by the Modification of Diet in Renal Disease Study equation. Cox-regression analysis was used to assess the hazard ratio and 95 % confidence intervals of CKD in quartiles of the total polyphenols.
In this study, 355 CKD cases over 11,058.464 person-years was reported. The median (IQR) age of participants was 36 years (27-46) at baseline. Moderate intake of lignans (≤ 6.8 mg) was negatively associated with the incidence of CKD in the adjusted model. No significant associations were detected between higher amounts of lignin and total polyphenols (HR: 0.97, 95 % CI 0.67-1.40) and CKD incidence.
Based on the current findings, moderate intake of lignin possess CKD-protective properties by approximately 32 %. No independent associations were observed between higher amounts of lignins and CKD incidence.
由于慢性肾脏病 (CKD) 是当前全球健康挑战之一,因此本研究旨在评估长期总多酚及其亚类的摄入量与 CKD 发病率之间的关系。
本研究从德黑兰血脂和血糖研究人群中选择了 3021 名伊朗成年人(47%为男性,年龄 20-79 岁)作为研究对象,这些人在基线时没有 CKD 诊断。通过验证过的食物频率问卷评估总多酚及其主要亚类(类黄酮、酚酸、白藜芦醇和木脂素)的摄入量,并将其分为类黄酮、酚酸、白藜芦醇和木脂素。尽管肾脏形态异常或持续 3 个月的尿液分析可以明确界定 CKD,但肾小球滤过率(eGFR)降低被认为是肾功能更准确的指标。因此,本研究中 eGFR<60 mL/min/1.73m 是 CKD 诊断的唯一指标。通过改良肾脏病饮食研究方程计算 eGFR。Cox 回归分析用于评估总多酚四分位数与 CKD 风险比和 95%置信区间。
本研究报告了 355 例 CKD 病例和 11058.464 人年。参与者在基线时的中位(IQR)年龄为 36 岁(27-46)。在调整模型中,木脂素(≤6.8mg)的适度摄入量与 CKD 的发病呈负相关。未发现较高木脂素和总多酚(HR:0.97,95%CI 0.67-1.40)与 CKD 发病之间存在显著关联。
根据目前的研究结果,适度摄入木脂素可使 CKD 的发病率降低约 32%。未观察到较高木脂素与 CKD 发病率之间存在独立关联。